Exact Sciences Corp 2022 SR
The report highlights Exact Sciences' progress in cancer diagnostics, surpassing 12 million people tested and achieving record revenue of $2.1 billion in 2022. Key achievements include the first-time reporting of Scope 3 emissions and the completion of a materiality assessment. The company also expanded its talent attraction and development programs, maintaining its Great Place to Work certification for the fourth consecutive year. Environmental efforts focused on energy efficiency and waste management, with 46% of total waste recycled.
Company: Exact Sciences Corp
Sector: Healthcare & social services
Country: United States
Year: 2022
Type: SR
Pages: 72
Back to company
Exact Sciences Corp
ESG Report
The report highlights Exact Sciences' progress in cancer diagnostics, surpassing 12 million people tested and achieving record revenue of $2.1 billion in 2022. Key achievements include the first-time reporting of Scope 3 emissions and the completion of a materiality assessment. The company also expanded its talent attraction and development programs, maintaining its Great Place to Work certification for the fourth consecutive year. Environmental efforts focused on energy efficiency and waste management, with 46% of total waste recycled.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2022
Reporting Period
Jan 1, 2022 - Dec 31, 2022
Fiscal Year
2022
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Other Standards
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Scope 3:
Energy Consumption
Renewable Energy
Water Consumption
Total Waste
Women on Board
Women in Management
Workplace Fatalities
Employees